Ramón Aranda

ORCID: 0000-0002-6788-7668
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Cardiac Structural Anomalies and Repair
  • Congenital Heart Disease Studies
  • Rabies epidemiology and control
  • Atrial Fibrillation Management and Outcomes
  • Bartonella species infections research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Poisoning and overdose treatments
  • Venous Thromboembolism Diagnosis and Management
  • Blood transfusion and management
  • Efficiency Analysis Using DEA
  • Cardiac tumors and thrombi
  • Diagnosis and Treatment of Venous Diseases
  • Cardiac Arrhythmias and Treatments
  • Diabetes Treatment and Management
  • Receptor Mechanisms and Signaling
  • Cardiac electrophysiology and arrhythmias
  • Blood Pressure and Hypertension Studies
  • Pharmacology and Obesity Treatment
  • Streptococcal Infections and Treatments
  • Acute Ischemic Stroke Management
  • Viral Infections and Immunology Research
  • Central Venous Catheters and Hemodialysis

Universitat de Barcelona
2024

Hospital Clínic de Barcelona
2024

Hospital Universitario Virgen de la Arrixaca
2019-2023

Pro Criança Cardíaca
2023

Instituto Murciano de Investigación Biosanitaria
2021

Glucagon is thought to increase heart rate and contractility by stimulating glucagon receptors increasing 3',5'-cyclic adenosine monophosphate (cAMP) production in the myocardium. This has been confirmed animal studies but not human heart. The cardiostimulatory effects of have correlated with degree cardiac dysfunction, as well enzymatic activity phosphodiesterase (PDE), which hydrolyses cAMP. In this study, presence inotropic chronotropic samples failing nonfailing (NF) hearts were...

10.1186/s12933-023-01859-8 article EN cc-by Cardiovascular Diabetology 2023-05-30
Daniel H. Newton Manuel Monreal Bosch Michael Amendola Luke G. Wolfe Cristina Pérez Ductor and 95 more Ramón Lecumberri Mark Levy Manuel Monréal Hervé Decousus Paolo Prandoni Benjamin Brenner Raquel Barba Pierpaolo Di Micco Laurent Bertoletti Inna Tzoran Abílio Reis Marijan Bosevski Henri Bounameaux Radován Malý Philip Wells Manolis Papadakis Ramón Agüero Miguel Ángel Aibar Arregui María Alfonso Ramón Aranda Juan I. Arcelus Raquel Barba M. Barrón B. Barrón‐Andrés José Bascuñana J. Binetti Á. Blanco-Molina Tulio Bueso I. Cañas Fábio Carmona N. Chic Alex Culla Roberto del Pozo J. del Toro Carmen Díaz‐Pedroche J.A. Díaz‐Peromingo C. Falgá C. Fernández‐Aracil Carmen Fernández‐Capitán M.A. Fidalgo Carme Font Llorenç Font P. Gallego Marian García-Núñez F. García‐Bragado Vicente Gómez del Olmo J. González E Grau A. Grimón L. Guirado Juan Mata G. Hernández-Comes Luis Blasco Luis Jara‐Palomares M.J. Jaras David Jiménez M.D. Joya Ramón Lecumberri J.L. Lobo Luciano López-Jiménez Raquel López-Reyes J.B. López‐Sáez M.A. Lorente A. Lorenzo I. Manrique-Abos Pablo Javier Marchena Miren Martín García J.M. Martín‐Antorán F. Martín‐Martos Manuel Monréal José Antonio Nieto Santiago Nieto Antonio Rodrı́guez-Núñez Manuel Jesús Núñez S. Otálora Remedios Otero B. Pagán José María Pedrajas Gustavo Pérez Ignacio Sánchez Pérez C. Pérez‐Ductor M.L. Peris José Antonio Porras Òscar Reig Antoni Riera‐Mestre David Riesco A. Rivas M.A. Rodríguez‐Dávila V. Rosa E. Rosillo-Hernández Pedro Ruiz‐Artacho N. Ruiz‐Giménez Joan Carles Sahuquillo M.C. Sala‐Sainz A. Sampériz

10.1016/j.jvsv.2016.08.002 article EN Journal of Vascular Surgery Venous and Lymphatic Disorders 2016-10-27

Abstract OBJECTIVES The Edwards Intuity valve is a rapid deployment aortic prosthesis that favours less invasive approaches. However, evidence about the clinical behaviour of their smaller sizes scarce. Herein, we studied haemodynamic behaviours and outcomes small prostheses (19–21 mm) in comparison to larger (>21 mm). METHODS This an observational study including patients implanted with prosthesis. Patients 19–21 >21 mm were included. Baseline perioperative variables, as well...

10.1093/icvts/ivab175 article EN Interactive Cardiovascular and Thoracic Surgery 2021-05-21

This case report illustrates how to implant a central paracorporeal temporary biventricular assist device in 17-year-old patient with acute heart failure due fulminant form of coronavirus disease 2019 myocarditis. The procedure was carried out after prior veno-arterial extracorporeal membrane oxygenation support. Myocardial biopsies and explants are also included the report. weaned on postoperative day 6 discharged without any significant complications. One year event, remains asymptomatic...

10.1510/mmcts.2024.031 article EN Multimedia Manual of Cardio-Thoracic Surgery 2024-07-05

Objective: Modern medicine restricts the transfusion of RBC concentrates. Valvular heart surgery is one first clients blood banks. We performed an analysis to determine perioperative factors associated with autologous red cell concentrates in patients undergoing aortic valve replacement Edwards Intuity prostheses. Methods: Patients who underwent prosthesis were studied. Logistic regression was independent Results: Seventy-two (68% males, 75.6 ± 4.8 years) included. Thirteen (18%) urgent....

10.1080/24748706.2019.1589826 article EN cc-by-nc-nd Structural Heart 2019-01-01

Objective: Aortic prostheses with rapid deployment have recently emerged shorter surgical times and less invasive approaches for the treatment of aortic stenosis. The appearance via TAVR has caused calculation preoperative risk to become more interesting select right treatment. We studied prognostic utility 5 scales (Euroscore logistic, EuroScore II, STSAVR score, NNEAVRscore OntarioScore) detect mortality in a cohort patients who received prostheses. Methods: From September 2012 November...

10.1080/24748706.2019.1591077 article EN cc-by-nc-nd Structural Heart 2019-01-01

Objective: Postoperative atrial fibrillation is the most frequent complication in cardiac surgery. Its cause not determined and its presence increases complications economic cost. Rapid deployment aortic prostheses are a novelty surgery they allow surgical times to be reduced. We conducted study determine incidence predictors of postoperative valve with these prostheses. Methods: Patients operated on for valvular who were implanted an Edwards Intuity rapid-deployment biological prosthesis...

10.1080/24748706.2019.1589796 article EN cc-by-nc-nd Structural Heart 2019-01-01

Objective: Aortic prostheses of rapid deployment have recently emerged for the treatment aortic stenosis. They reduce surgical times and facilitate less invasive approaches. However, these seem to a higher risk permanent pacemaker implantation in immediate postoperative period. We conducted study determine incidence predictors pacemakers patients with prostheses. Methods: All who were implanted consecutively an Edwards Intuity prosthesis recruited. Logistic regression was performed...

10.1080/24748706.2019.1589828 article EN cc-by-nc-nd Structural Heart 2019-01-01

Objective: Patients with congenital heart disease (CHD) and valve dysfunction requiring surgery present a challenge for surgical treatment. Most of these patients have complex anatomy undergone previous cardiac procedures. Durability bioprosthesis in any position has been reported to be suboptimal this population. The INSPIRIS prosthesis (Edwards Lifesciences) new pericardial tissue (RESILIA) could improve hemodynamic performance durability. It also an expandable frame future valve-in-valve...

10.1080/24748706.2020.1715716 article EN cc-by-nc-nd Structural Heart 2020-01-01

Las prótesis aorticas de rápido despliegue aparecieron hace 10 años para tratar la estenosis aórtica. El sistema válvula Edwards Intuity es una biológica basada en Magna con un marco infraanular. Presentamos los resultados clínicos y hemodinámicos a corto largo plazo obtenidos esta biológica. Ciento diecisiete pacientes (65% varones, 75 ± 4,5 años) aórtica (gradiente medio preoperatorio 49,6 12 mm Hg) recibieron entre septiembre 2012 diciembre 2019. Se incluyeron base datos prospectiva que...

10.1016/j.circv.2020.08.002 article ES cc-by-nc-nd Cirugía Cardiovascular 2020-10-20

Objectives: Rapid deployment Aortic valves have become an alternative for aortic valve stenosis treatment in recent years. Edwards Intuity was developed over Perimount Magna Ease design, with the addition of infraannular ballon-expandable frame. So, we could hypothesize that outcomes should be similar between both protheses. Very few studies compared these kinds We communicate our experience prostheses.Methods: Retrospective observational study 392 patients who receive replacement a single...

10.1080/24748706.2021.1898890 article EN cc-by-nc-nd Structural Heart 2021-04-09

Objective: The Edwards Intuity valve is a rapid deployment biological aortic prosthesis. It another option to treat stenosis. favors less aggressive approaches and shortens surgical times. Little known about the hemodynamic clinical behavior of their smaller sizes. We present our experience with prostheses Nos. 19 21.Methods: From September 2012 May 2020, 122 were implanted, 54 (45%) no. or 21 (69% women, 76 (72-78) years).Results: One patient (1.8%) died in hospital six follow-up (3.4%)....

10.1080/24748706.2021.1898901 article EN cc-by-nc-nd Structural Heart 2021-04-09

Objective: Upper hemisternotomy in aortic valve surgery has been used for 20 years. Rapid deployment prostheses facilitate the use of less invasive approaches and shorten surgical times. Our objective is to compare a series patients who received Edwards Intuity Deployment Aortic Prosthesis via or full sternotomy.Methods: From September 2012 December 2019, 109 with isolated severe stenosis prosthesis (63% male, 75 ± 4.5 years).Results: Overall mortality was 2.8%, 70% underwent upper...

10.1080/24748706.2021.1898895 article EN cc-by-nc-nd Structural Heart 2021-04-09

Objective: Rapid deployment aortic valves appeared ten years ago to treat stenosis. The Edwards Intuity Valve System is a biological prosthesis based on the Magna valve with an infra-annular framework. We present short and intermediate-term clinical hemodynamic results obtained this prosthesis.Methods: One hundred twenty-two patients (63% male, 75 ± 4.5 years) stenosis (mean preoperative gradient of 49.4 12.5 mm Hg) received between September 2012 May 2020. They were included in prospective...

10.1080/24748706.2021.1898902 article EN cc-by-nc-nd Structural Heart 2021-04-09
Coming Soon ...